Compositions that specifically bind to colorectal cancer cells and methods of using the same
US6060037A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Apr 26, 1996 |
| Grant date | May 9, 2000 |
| Priority date | — |
| Expiry date | Apr 26, 2016 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/245
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Conjugated compounds which comprise an ST receptor binding moiety and a radiostable active moiety are disclosed. Pharmaceutical compositions comprising conjugated compound which comprises an ST receptor binding moiety and a radiostable active moiety or an ST receptor binding moiety and a radioactive active moiety are disclosed. Methods of treating an individual suspected of suffering from metastasized colorectal cancer are disclosed. Methods of radioimaging metastasized colorectal cancer cells are disclosed. In vitro methods, kits and reagents are disclosed for determining whether or not an individual has metastasized colorectal cancer cells, for determining whether tumor cells are colorectal in origin and for analyzing tissue samples from the colon tissue to evaluate the extent of metastasis of colorectal tumor cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.